AstraZeneca PLC
[WKN: 886455 | ISIN: GB0009895292]
Aktienkurse
147,025€ -0,63%
Echtzeit-Aktienkurs AstraZeneca PLC
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

UBS stuft ASTRAZENECA auf Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 13000…

AstraZeneca acquires Gracell

27 December 2023 AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases Includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic…

Wainua (eplontersen) granted first US FDA approval

22 December 2023 Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated…

AstraZeneca Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…

AstraZeneca to acquire Icosavax

News Release Regulatory News Service 12 December 2023 AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase…

ALLR: Stenoparib Clinical Update

By John Vandermosten, CFA NASDAQ:ALLR Early Results - Phase II Stenoparib Allarity Therapeutics, Inc. (NASDAQ:ALLR) provided an update to investors on its…